SCHEMBL9609404

SCHEMBL9609404

O=c1c2ccccc2n(CCOc2ccccc2)c2ccc([S+](c3cc(F)c(F)c(F)c3)c3cc(F)c(F)c(F)c3)cc12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 3/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ TSHR P16473 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ PTGS2 P35354 3/20 0.37
▸ MAPT P10636 1/20 0.37
▸ PPARG P37231 2/20 0.37
▸ PPARA Q07869 2/20 0.37
▸ PPARD Q03181 1/20 0.37
▸ RXFP1 Q9HBX9 2/20 0.37
▸ LMNA P02545 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ P2RX4 Q99571 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609427 0.84 MAPT (0.42) SMN1; SMN2ALDH1A1MAPTRXFP1TP53
SCHEMBL9609422 0.81 P2RX4 (0.58) MEN1KMT2ASMN1; SMN2MAPK1ALDH1A1
SCHEMBL9609426 0.74 P2RX4 (0.45) MEN1KMT2ASMN1; SMN2MAPK1ALDH1A1
SCHEMBL9609397 0.71 ATM (0.50) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL9609399 0.69 GLA (0.62) ALDH1A1POLB
SCHEMBL9609425 0.68 HDAC6 (0.41) SMN1; SMN2MAPK1ALDH1A1MAPTRXFP1
SCHEMBL9609428 0.67 ATM (0.62) MEN1KMT2ARAB9AMAPK1NPC1
SCHEMBL9609412 0.67 L3MBTL1 (0.46) KCNA3MEN1KMT2ARAB9ATSHR
SCHEMBL9609410 0.66 JAK2 (0.44) KMT2ASMN1; SMN2MAPK1MAPTRXFP1
SCHEMBL9609417 0.65 P2RX4 (0.61) MEN1KMT2ASMN1; SMN2MAPK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073854-B2 Aromatic sulfonium salt compound ADEKA CORPORATION (JP) 2015-07-07 — — US disclosed
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND ADEKA CORPORATION (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136155-A1 AROMATIC SULFONIUM SALT COMPOUND F12, ASIC1, SPIN1 KCNA3 1089/4885MEN1 1116/4885KMT2A 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback